|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
IRCT |
|
Last refreshed on:
|
22 February 2018 |
|
Main ID: |
IRCT2014070118202N2 |
|
Date of registration:
|
2014-07-10 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Routine use of next generation sequencing (NGS) for preimplantation genetic diagnostics (PGD) of blastomeres obtained from embryos on day 3 in fresh IVF cycles.
|
|
Scientific title:
|
Routine use of next generation sequencing (NGS) for preimplantation genetic diagnostics (PGD) of blastomeres obtained from embryos on day 3 in fresh IVF cycles. |
|
Date of first enrolment:
|
2014-08-01 |
|
Target sample size:
|
28 |
|
Recruitment status: |
Complete |
|
URL:
|
http://en.irct.ir/trial/16581 |
|
Study type:
|
interventional |
|
Study design:
|
Randomization: Not randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Diagnostic.
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Poland
| | | | | | | |
|
Contacts
|
|
Name:
|
Judyta Zabielska
|
|
Address:
|
ul. Trzy lipy 3
Gdansk
Poland |
|
Telephone:
|
00485858 58 810 |
|
Email:
|
judyta.zabielska@invicta.pl |
|
Affiliation:
|
Invicta Gdansk |
|
|
Name:
|
Judyta Zabielska
|
|
Address:
|
GPNT ul. Trzy lipy 3
Gdansk
Poland |
|
Telephone:
|
00485858 58 810 |
|
Email:
|
judyta.zabielska@invicta.pl |
|
Affiliation:
|
Invicta Fertility and Reproductive Centre |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Incusion:
1. Patients undergoing in vitro fertilization in Invicta Fertility and Reproductive Centre s. z o.o. in time frame from 08.2014 to 01.2015
Exclusion:
1. Patients who did not received embryo transfer in first cycle
2. Lack of data/results according to 5 verifications (that means 6-8 week after embryo transfer)
Exclusion criteria:
Age minimum:
31 years
Age maximum:
38 years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Female infertility, unspecified
|
infertility.
Female infertility, unspecified
|
|
Intervention(s)
|
|
Next Generation Sequencing Preimplantation Genetic Diagnosis embryo selection
|
|
Diagnosis
|
|
Next Generation Sequencing Preimplantation Genetic Diagnosis embryo selection.
|
|
Primary Outcome(s)
|
|
Pregnancy rate. Timepoint: on 6 weeks and 1-3 days. Method of measurement: clinical poregnancy (as ultrasound fetal heartbeat detection).
|
|
Secondary Outcome(s)
|
|
Implantation rate. Timepoint: 7 day after tansfer. Method of measurement: blood serum beta-HCG concentration.
|
|
Source(s) of Monetary Support
|
|
Invicta s.z o.o.
|
|
Ethics review
|
Status: Approved
Approval date:
Contact:
Komisja Bioetyczna przy Okregowej Izbie Lekarskiej
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|